Skip to content
2000
Volume 20, Issue 7
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Limitations on the pharmacotherapy and a high prevalence worldwide are critical issues related to depression and cancer. It has been discussed that a dysregulation of intracellular Ca2+ homeostasis is involved in the pathogenesis of both these diseases. In addition, depression raises the risk of cancer incidence. Consistent data support the concept that depression is an independent risk issue for cancer. However, the cellular mechanisms involved in this link between depression and cancer remain uncertain. Considering our previous reports about Ca2+ and cAMP signalling pathways (Ca2+/cAMP signalling), I herein discussed the putative contribution of Ca2+/cAMP signalling in this link between depression and cancer. Moreover, it is important to take depression into account during the process of prevention and treatment of cancer.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520620666200220113817
2020-05-01
2025-04-21
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520620666200220113817
Loading

  • Article Type:
    Review Article
Keyword(s): Ca2+/cAMP signaling; cancer; Depression; homeostasis; pharmacotherapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test